Early phase clinical trial Palliative care Value clarification tool Patient-physician communication
Conditions
Interventions
n.a.
Sponsors
Erasmus MC, Rotterdam
Antoni van Leeuwenhoek, Amsterdam
UMC Utrecht
Eligibility
Inclusion criteria
Inclusion criteria: For the patients: - Diagnosed with advanced cancer for whom standard systemic therapy is not or no longer available; - medically fit enough to be offered participation in early phase clinical trials; - aged 18 years or older;v - sufficient command of the Dutch language; - written informed consent. For the (healthy) oncologists: - member of a trial oncologists (study) team.
Exclusion criteria
Exclusion criteria: For the patients: - Cognitive impairment (e.g. dementia) according to the medical record; - no access to the Internet.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| For WP1, the main study endpoint will be the delivery of a ready to implement online value clarification tool. For WP2 this will be decisional conflict measured by the Dutch version of the Decisional Conflict Scale (DCS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study parameters for WP1 include the life values of patients, experiences with patient-physician communication, and the fit and value of the online value clarification tool. Secondary outcomes for WP2 include the communication process, decision making process, discussion of patients’ values and preferences, consultation duration, and actual usage of the tool. | — |
Contacts
Public ContactC.C.D. Rijt, van der
Erasmus Medical Center, Daniel den Hoed Cancer Center, P.O. Box 5201
Outcome results
None listed